Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000439887

Medchemexpress LLC KCL-286 | 1952276-71-9 | 98.9% | 334.33 | 25 MG
SDP

Catalog No. 5000439887
Encompass_Preferred

KCL-286 is an orally active and brain-penetrant retinoic acid receptor (RAR) β2 agonist. It targets RARβ2 with selectivity over RAR α and RAR γ, activating RARβ2 in injured neurons. This compound induces axonal regeneration of both spinal and sensory nerves through the inhibitory environment of the CNS, modulates neuroinflammation, and extracellular matrix molecules.

  • Orally active and brain-penetrant RAR β2 agonist
  • Selectivity for RARβ2 over RAR α and RAR γ
  • Activates RARβ2 in injured neurons
  • Induces axonal regeneration of spinal and sensory nerves
  • Modulates neuroinflammation and extracellular matrix molecules
  • Can modulate CSPG expression by neuronal secretion of decorin to promote myelination and axonal growth
  • Potential for research in spinal cord injury and traumatic nerve injury

Catalog No. 50-004-39887 Supplier Medchemexpress LLC Supplier No. 25MGHY111573
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KCL-286 is an orally active and brain-penetrant retinoic acid receptor (RAR) β2 agonist. It targets RARβ2 with selectivity over RAR α and RAR γ, activating RARβ2 in injured neurons. This compound induces axonal regeneration of both spinal and sensory nerves through the inhibitory environment of the CNS, modulates neuroinflammation, and extracellular matrix molecules.

  • Orally active and brain-penetrant RAR β2 agonist
  • Selectivity for RARβ2 over RAR α and RAR γ
  • Activates RARβ2 in injured neurons
  • Induces axonal regeneration of spinal and sensory nerves
  • Modulates neuroinflammation and extracellular matrix molecules
  • Can modulate CSPG expression by neuronal secretion of decorin to promote myelination and axonal growth
  • Potential for research in spinal cord injury and traumatic nerve injury

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.